Chinese Journal of Osteoporosis · Nov 12, 2026

Research advances in traditional Chinese medicine interventions for postmenopausal osteoporosis based on lipid–bone metabolism

By 邵顺康

Postmenopausal osteoporosis (postmenopausal osteoporosis,PMOP) is a systemic disease closely associated with disordered lipid metabolism, and its pathogenesis involves abnormal accumulation of bone marrow fat and an imbalance between osteogenic and adipogenic differentiation. Traditional Chinese medicine has the advantage of regulating lipid–bone metabolism through multiple targets in the treatment of PMOP. Starting with the mechanisms of interactions between lipid and bone metabolism and incorporating the traditional Chinese medicine theory of pathogenesis involving “kidney essence deficiency–impaired spleen transportation and transformation–blood stasis obstructing the collaterals,” this article summarizes the mechanisms by which traditional Chinese medicine regulates lipid–bone metabolism through the ferroptosis pathway, the PPAR signaling pathway, adipose-derived exosomes, and the Wnt/β-catenin pathway, as well as the effects of individual Chinese medicinal herbs such as Epimedium and Drynaria rhizome and compound formulas such as Bushen Huoxue Formula and Erxian Decoction on improving bone microarchitecture. Future research can use multiomics technologies to further investigate the mechanisms of traditional Chinese medicine in treating PMOP and provide new ideas for its prevention and treatment.

doi.org/10.3969/j.issn.1006-7108.2026.10.013Interventions

AgingResearch.News